Signal Transduction of C-Terminal Phosphorylation Regions for Equine Luteinizing Hormone/Chorionic Gonadotropin Receptor (eLH/CGR)

Munkhzaya Byambaragchaa1, Hyo-Eun Joo2, Sang-Gwon Kim2, Yean-Ji Kim2, Gyeong-Eun Park2, Kwan-Sik Min1,2,
Author Information & Copyright
1Institute of Genetic Engineering, Hankyong National University, Anseong 17579, Korea
2Division of Animal Science, School of Animal Life Convergence Sciences, Hankyong National University, Anseong 17579, Korea
Corresponding author Kwan-Sik Min, Division of Animal Science, School of Animal Life Convergence Sciences, Hankyong National University, Anseong 17579, Korea Tel: +82-31-670-5421, E-mail:

© Copyright 2022 The Korean Society of Developmental Biology. This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Received: Dec 03, 2021 ; Revised: Jan 04, 2022 ; Accepted: Feb 12, 2022

Published Online: Mar 31, 2022


This study aimed to investigate the signal transduction of phosphorylation sites at the carboxyl (C)-terminal region of equine luteinizing hormone/chorionic gonadotropin receptor (eLH/ CGR). The eLH/CGR has a large extracellular domain of glycoprotein hormone receptors within the G protein-coupled receptors. We constructed a mutant (eLH/CGR-t656) of eLH/ CGR, in which the C-terminal cytoplasmic tail was truncated at the Phe656 residue, through polymerase chain reaction. The eLH/CGR-t656 removed 14 potential phosphorylation sites in the intracellular C-terminal region. The plasmids were transfected into Chinese hamster ovary (CHO)-K1 and PathHunter Parental cells expressing β-arrestin, and agonist-induced cAMP responsiveness was analyzed. In CHO-K1 cells, those expressing eLH/CGR-t656 were lower than those expressing eLH/CGR wild-type (eLH/CGR-wt). The EC50 of the eLH/ CGR-t656 mutant was approximately 72.2% of the expression observed in eLH/CGR-wt. The maximal response in eLH/CGR-t656 also decreased to approximately 43% of that observed in eLH/CGR-wt. However, in PathHunter Parental cells, cAMP activity and maximal response of the eLH/CGR-t656 mutant were approximately 173.5% and 100.8%, respectively, of that of eLH/CGR-wt. These results provide evidence that the signal transduction of C-terminal phosphorylation in eLH/CGR plays a pivotal role in CHO-K1 cells. The cAMP level was recovered in PathHunter Parental cells expressing β-arrestin. We suggest that the signal transduction of the C-terminal region phosphorylation sites is remarkably different depending on the cells expressing β-arrestin in CHO-K1 cells.

Keywords: equine luteinizing hormone/chorionic gonadotropin receptor (eLH/CGR); Chinese hamster ovary (CHO)-K1 cells; PathHunter Parental cells; Phosphorylation sites; Signal transduction


The family of glycoprotein hormone receptors including lutropin chorionic gonadotropin hormone receptor (LH/CGR) belongs to the superfamily of G protein-coupled receptors (GPCRs) that couple extracellular agonists to intracellular effector molecules through the reactions of heterotrimeric G proteins and arrestins (Pierce et al., 2002; Martemyanov & Garcia-Maarcos, 2018; Wan et al., 2018; Seong et al., 2020; Jones et al., 2021). A β-arrestin recruitment to ligand-stimulated GPCRs promotes non-canonical signaling cascades follow by GPCR desensitization and endocytosis (Beautrait et al., 2017; Pakharukova et al., 2020; Slosky et al., 2020).

GPCR internalization is a specific process triggered by agonist stimulation, following desensitization of the signaling function of receptors, and increases cAMP responsiveness (Min et al., 1998; Kim et al., 2019; Byambaragchaa et al., 2020; Min et al., 2021). Protein phosphorylation sites in various signaling pathways are important in regulating cell proliferation (Seong et al., 2020). The gonadotropin hormone receptors, LH/CGR, and follicle-stimulating hormone receptor (FSHR) in humans, rats, mice, and horses are highly conserved regions within the transmembrane helices (Min et al., 1998; Zhang et al., 2007; Byambaragchaa et al., 2018).

In the carboxyl (C)-terminal deleted mutant, the rat LHR (rLHR)-5S/T→A mutant was considerably decreased in cAMP responsiveness, and the rate of internalization was significantly slower compared to the wild-type rLHR (rLHR-wt) (Wang et al., 1997). Two deleted mutants (rLHR-t628 and rLHR-t631) in the rLHR C-terminus are involved in the protein kinase A (PKA) signaling pathway, desensitization, and downregulation by phorbol 12-myristate-13-acetate (PMA) and human chorionic gonadotropin (hCG) treatment (Sánchez-Yagüe et al., 1992; Wang et al., 1996). Recently, we also reported that EC50 and Rmax levels of the equine FSHR (eFSHR)-t641 mutant, which removed 10 potential phosphorylation sites, were 0.58-fold and 68.4% of that in eFSHR-wt (Seong et al., 2020). The EC50 level of eel FSHR-t614 mutant, in which 10 phosphorylation sites in the C-terminal region were deleted, was approximately 60.4% in Chinese hamster ovary (CHO) -K1 cells, and the maximal response was drastically lower than that of eel FSHR-wt (Kim et al., 2018). However, this mutant showed a similar cAMP response in PathHunter Parental cells expressing β-arrestin, despite being slightly lower. Thus, the deletion of phosphorylation sites in the C-terminal intracellular region is extremely important for preventing phosphorylation post-translation and retarding or preventing hCG- or PMA-induced uncoupling.

Other studies have shown that agonist-induced activation and phosphorylation of rFSHR are not essential for internalization (Nakamura et al., 1998). However, the rFSHR-t635 mutant contains only one potential phosphorylation site in the intracellular region and responds to increases in the cAMP response (Hipkin et al., 1995a), demonstrating that the mutant is not inhibited in the signal transduction pathway of phosphorylation or uncoupling (Ascoli, 1996). With respect to the truncation of phosphorylation sites, a dramatical loss of cAMP responsiveness in hFSHR-t678 has been reported (Krishnamurthy et al., 2003; Bhaskaran & Ascoli, 2005), the hLHR-t682 mutant is slower at the cell surface loss of the receptor than that of hLHR-wt (Bhaskaran & Ascoli, 2005), and the hLHR-t682 complex with hCG is routed to a lysosomal degradation pathway (Kishi et al., 2001; Hirakawa and Ascoli, 2003; Galet et al., 2004).

Therefore, the C-terminal region of eLH/CGR has 14 potential phosphorylation sites and a highly conserved leucine motif that is essential for trafficking (Duvernay et al., 2004; Byambaragchaa et al., 2021a,b,e). The eCG, secreted from the placenta during early pregnancy, is a unique molecule that displays both LH- and FSH-like activities in non-equid species (Min et al., 2019, 2020, 2021; Lee et al., 2021) and exhibits only LH-like activity in equine species (Lee et al., 2017, 2021; Park et al., 2017; Min et al., 2019, 2020; Byambaragchaa et al., 2021c,d).

Thus, the C-terminal region containing the phosphorylation sites in eLH/CGR must be determined for the elucidating the signal transduction and downregulated pathways. To characterize the signal transduction of the β-arrestin function through the eLH/CGR-eCG complex, we analyzed the agonist-stimulated cAMP response of both eLH/CGR-wt and eLH/CGR-t656.


1. Materials

The oligonucleotides used in this study were synthesized by Genotech (Daejeon, Korea). The cloning vector (pGEMT-T easy) was purchased from Promega (Madison, WI, USA). The pcDNA3 expression vector, pCMV-ARMS1-PK2 expression vector, Freestyle MAX reagent, FreeStyle CHO-suspension (CHO-S) cells and AssayComplete medium were purchased from Invitrogen (Carlsbad, CA, USA). The PathHunter Parental CHO-K1 cell line expressing β-arrestin 2 was purchased from DiscoveRx (San Diego, CA, USA). The pCORON1000 SP VSV-G-tag expression vector was purchased from Amersham Biosciences (Piscataway, NJ, USA). The PMSG-ELISA kit was purchased from DRG International (Mountainside, NJ, USA). Restriction enzymes and DNA ligation reagents were purchased from Takara Bio (Shiga, Japan). Fetal bovine serum (FBS) was obtained from HyClone Laboratories (Logan, UT, USA). The cAMP Dynamic 2 immunoassay kit was purchased from Cisbio (Codolet, France). CHO-K1 cells and HEK 293 cells were obtained from the Korean Cell Line Bank (KCLB, Seoul, Korea). The QIAprep-Spin plasmid kit was purchased from Qiagen (Hilden, Germany). All other reagents were obtained from Sigma-Aldrich (St. Louis, MO, USA).

2. Construction of eLH/CGR-wt and eLH/CGR-t656 mutant

The eLH/CGR cDNA was cloned using cDNA from equine testes and ovaries, as previously reported (Seong et al., 2020; Byambaragchaa et al., 2021). Polymerase chain reaction (PCR) fragments of the C-terminal deleted mutant were cloned into pGEMT and sequenced. The full fragments of the eLH/CGR-wt and eLH/CGR-t656 mutants were ligated into the pcDNA3 mammalian expression vector cut by the EcoRI and XhoI sites. For the PathHunter Parental CHO-K1 cells, eLH/CG cDNA digested using Nhe1 and Sac1 was cloned into the same enzyme sites as the pCMV-ARMS1-PK2 expression vector, as previously described (Seong et al., 2020). The eLH/CGR-wt and eLH/CGR-t656 mutants were subcloned into the pVSVG expression vector using XhoI and EcoRI and the entire region of the deleted mutant was confirmed by DNA sequencing. Fig. 1 presents a schematic representation of the eLH/CGR intracellular region and the truncated mutant, in which the potential phosphorylation sites were deleted after amino acid residue 656. There was no stop codon in the C-terminal region (Sac1 enzyme site) of the pCMV-ARMS1-PK2 expression vector. The direction was confirmed by restriction mapping and verified by sequencing the entire open reading frame. Fig. 2 shows the PCR products of eLH/CGR full-length and t656 mutant cDNAs, and these receptor fragments were cloned into each expression vector, pcDNA3, pVSVG, and pCMV-ARMS1-PK2.

Fig. 1. Schematic representation of the intracellular region of equine luteinizing hormone/chorionic gonadotropin receptor (eLH/CGR). The amino acid sequence of the three cytoplasmic loops and the C-terminal cytoplasmic tail of eLH/CGR are shown. The 15 potential phosphorylation sites (serine and threonine residues) are shown. The truncation site (t656) is deleted after the 656th amino acid. The eLH/CGR-t651 mutant has only one potential phosphorylation site at the serine residue. The amino acid sequence was amplified with equine ovary and testis cDNA from our laboratory and sequenced as described by Byambaragchaa et al. (2020). Adapted from Byambaragchaa et al. (2020) with CC-BY.
Download Original Figure
Fig. 2. PCR amplification. The cDNA samples were amplified by polymerase chain reaction (PCR) method. PCR was performed using eLH/CGR full-length primers and deleted mutant primers at the phosphorylation sites of the carboxyl-terminal peptide regions. The amplified cDNA samples were sequenced and subcloned into pcDNA3, pVSVG, and prolink mammalian expression vector. M, DNA markers; WT, wild type; t656; deleted mutant after the 656th amino acid residue. eLH/CGR, equine luteinizing hormone/chorionic gonadotropin receptor.
Download Original Figure
3. Production of rec-eCG protein

For rec-eCG production, the vectors were transfected into CHO-S cells using FreeStyleTM MAX reagent, as previously described (Byambargachaa et al., 2021e). The CHO-S cells were cultured in FreeStyle CHO expression medium at 1×107 cells per 30 mL of medium for 3 days. After transfection with the expression vectors, the culture medium was collected on Day 7 post-transfection and centrifuged at 100,000×g for 10 min at 4℃. The supernatant was collected and concentrated using a Centricon filter. Finally, the sample was mixed 10–20 times and the quantity of rec-eCG was determined using ELISA as previously reported (Byambaragchaa et al., 2021c,d).

4. Transient transfection of eLH/CGR-wt and eLH/CGR-t656 mutant into CHO-K1 cells and PathHunter Parental cells

CHO-K1 cells were cultured in a growth medium [Ham’s F-12 medium containing antibiotics (penicillin and streptomycin), glutamine (2 mM), and 10% FBS]. PathHunter Parental cells were engineered to stably express an enzyme acceptor-tagged β-arrestin fusion protein. These cells were transiently transfected according to the supplier’s protocol as previously described (Seong et al., 2020). The CHO-K1 cells and PathHunter Parental cells were grown to 80%–90% confluence in 6-well plates. The diluted plasmid DNAs were transfected using Lipofectamine reagent. After 5 min, growth medium containing 20% FBS was added to each well. Transfected cells were adjusted for cAMP analysis 48–72 h post-transfection.

5. Analysis of cAMP levels by homogeneous time-resolved fluorescence (HTRF) assays

cAMP accumulation in the CHO-K1 cells and PathHunter Parental cells expressing eLH/ CGR-wt and eLH/CGR-t656 mutants was measured using cAMP Dynamics 2 competitive immunoassay kits as described previously (Byambaragchaa et al., 2021e). The cAMP response assay used a cryptate-conjugated anti-cAMP monoclonal antibody and a d2-labeled cAMP reagent. Transfected cells were seeded in a 384-well plate at 10,000 cells per well. Compound medium buffer containing the ligand (5 μL) was added to each well and incubated for 30 min. Subsequently, cAMP-d2 and anti-cAMP-cryptate were added to each well and incubated for 1 h at room temperature. The plate was detected by measuring compatible homogeneous time-resolved fluorescence (HTRF) energy transfer (665 nm/620 nm) using a TriStar2 S LB942 mi microplate reader (BERTHOLD Tech., Wildbad, Germany). The results were represented as Delta F% (cAMP inhibition), which was calculated as [Delta F% = (Standard or sample ratio-Sample negative) × 100/ Ratio negative]. The cAMP concentration for Delta F% values was calculated using the GraphPad Prism software (version 6.0; GraphPad Software, La Jolla, CA, USA).

6. Data analysis

GraphPad Prism 6.0 (San Diego, Ca, USA) was used for analyzing cAMP response, EC50 levels, and the stimulation curve analyses. Curves fitted in a single experiment were normalized to the background signal measured for mock-transfected cells.


1. Vector constructions

As a type of GPCR, eLH/CGR-wt has a long C-terminal region containing approximately 14 phosphorylation sites. As shown in Fig. 1, potential phosphorylation sites were deleted by PCR to assess the function of phosphorylation in signal transduction through cAMP responsiveness. The eLH/CGR-t565 mutant was deleted from the 45 amino acids containing 14 phosphorylation sites in the C-terminal region of eLH/CGR. The PCR results for the eLH/CGR-wt and eLH/ CGR-t656 mutants are shown in Fig. 2. The full fragments of the eLH/CGR-wt and eLH/ CGR-t656 mutants were ligated into the pcDNA3 and pVSVG mammalian expression vectors to be expressed in CHO-K1 cells. The eLH/CG cDNAs were cloned into the pCMV-ARMS1-PK2 expression vector to be expressed PathHunter Parental CHO-K1 cells. Finally, we constructed six expression vectors: pcDNA3-eLH/CGR-wt, pcDNA3-eLH/CGR-t656, pVSVG-eLH/CGR-wt, pVSVG-eLH/CGR-t656, pCMV-ARMS1-PK2-eLH/CGR-wt, and pCMV-ARMS1-PK2-eLH/CGR-t656.

2. Responsiveness of cAMP in cells expressing eLH/CG-wt and eLH/CGR-t656 mutant

The eLH/CGR-wt and eLH/CG-t656 plasmids were transfected into CHO-K1 cells and PathHunter Parental cells expressing β-arrestin. The activity of cAMP responsiveness is expressed as Delta F%, as shown in Fig. 3. The standard curve was appropriately inhibited by increasing the concentration (0.17–712 nM). Receptor cells were treated with different concentrations (0.008–1,500 ng/mL) of rec-eCG. The Delta F% values were estimated to express the cAMP concentration (nM). The cAMP values increased in a dose-dependent manner relative to the ligand concentration in both CHO-K1 cells and PathHunter Parental cells (Fig. 4).

Fig. 3. Dose-dependent inhibition of cAMP accumulation by agonist-induced treatment (rec-eCG) in between CHO-K1 cells and PathHunter CHO cells expressing β-arrestin. Cells were transfected with eLH/CGR-wt and eLH/CGR-t656 cDNAs. The cells were adjusted for cAMP analysis 48 h after transfection (see Materials and Methods for details). The data were calculated on the basis of the 665 nm/620 nm ratio and expressed as Delta F% (cAMP inhibition), according to the following equation: [Delta F% = (Standard or sample ratio – Mock transfection) × 100 / Mock transfection]. The standard samples were prepared to cover an average range of 0.17–712 nM. A representative dataset was obtained from three independent experiments. CHO-cell, Chinese hamster ovary cells; PA CHO-cells, PathHunter Parental CHO cells; eLH/CGR-wt, equine luteinizing hormone/chorionic gonadotropin receptor-wild type; rec-eCG, recombinant equine chorionic gonadotropin.
Download Original Figure
Fig. 4. Total cAMP levels stimulated by recombinant eCG (rec-eCG) dose-dependent treatment in CHO-K1 cells and PathHunter Parental CHO-cells transfected with eLH/CGR-wt and eLH/ CGR-t656. The cells (10,000 cells per well) were dispensed into a 384-well plate at 48 h post-transfection. The cells were stimulated with rec-eCG in a medium containing 0.5 mM MIX for 30 min at room temperature. The cAMP d2 and anti-cAMP-cryptate were added and the reaction mix was incubated at room temperature for 1 h. Inhibition of cAMP accumulation was expressed as Delta F%. The cAMP nM values (1×104 cells) relative to the Delta F% value was recalculated using GraphPad Prism software. A representative dataset was obtained from three independent experiments. The blank circles represent the corresponding curves for the eLH/CGR wild-type. The marked circles were shown the cAMP response of the eLH/CGR-t656. eLH/CGR, equine luteinizing hormone/chorionic gonadotropin receptor; CHO-cells, Chinese hamster ovary cells; PA CHO-cells, PathHunter Parental CHO-cells; rec-eCG, recombinant equine chorionic gonadotropin.
Download Original Figure

In the CHO-K1 cells, the EC50 values of eLH/CGR-wt and eLH/CGR-t656 mutant was 18.7 ng/mL and 25.9 ng/mL, respectively. The activities of both receptors were approximately 72.2% in the eLH/CGR-t656 mutant compared to that in the eLH/CGR-wt. The Rmax level in the eLH/CGR-t656 mutant was 0.57-fold lower than that of the eLH/CGR-wt as shown in Table 1. Therefore, the C-terminal phosphorylation regions were critical for the signal transduction of cAMP responsiveness in CHO-K1 cells expressing the deleted receptor mutant. However, the EC50 value in the PathHunter Parental cells transfected with eLH/CGR-wt and eLH/CGR-t641 was 27.6 ng/mL and 15.9 ng/mL, respectively (Table 1). Truncation of the C-terminal region was approximately 1.78-fold higher than that of the wild type receptor. However, eLH/CGR-wt and eLH/CGR-t656 mutants had similar Rmax levels. Thus, the EC50 level and maximal response in CHO-K1 cells expressing the eFSHR-t656 mutant were remarkably lower than those in cells expressing eLH/CGR-wt. However, the results in PathHunter Parental cells displayed different patterns, indicating that the eLH/CGR-t656 mutant was considerably high. This suggests that phosphorylation sites in the eLH/CGR C-terminal region play a pivotal role in signal transduction in CHO-K1 cells. The decreased cAMP and Rmax levels in the C-terminal-deleted mutant were recovered as eLH/CGR-wt in PathHunter Parental cells. We believe that the expression of β-arrestin in PathHunter Parental cells is a major factor for increasing the EC50 value and Rmax level in the eLH/CGR-t656 mutant.

Table 1. Bioactivity of eLH/CG receptors in cells expressing eLH/CGR-wt and eLH/CGR-t656 mutant

Values are the means±SEM of triplicate experiments. Log (EC50) values were determined from the concentration-response curves from in vitro bioassays.

eLH/CG receptors cAMP responses
Basal1 (nM / 104 cells) Log (EC50) (ng/mL) Rmax2 (nM / 104 cells)
CHO-K1 cells eLH/CGR-wt 4.1±1.2 18.7 (14.1 to 27.8)3 51.7±1.7 (1-fold)
CHO-K1 cells eLH/CGR-t656 3.9±0.7 25.9 (19.2 to 39.7) 29.9±1.1 (0.57-fold)
PA CHO cells eLH/CGR-wt 6.2±1.5 27.6 (19.1 to 49.7) 53.0±2.4 (1-fold)
PA CHO cells eLH/CGR-t656 8.7±1.6 15.9 (10.7 to 28.4) 57.6±2.4 (1.08-fold)

1 Basal cAMP level average without agonist treatment.

2 Rmax average cAMP level/104 cells.

3 Geometric mean (95% confidence limit) of at least three experiment. eLH/CGR, equine luteinizing hormone/chorionic gonadotropin receptor; CHO, Chinese hamster ovary.

Download Excel Table


GPCR signals through coupling of G proteins and of β-arrestins alternatively activate beta-adrenergic-receptor kinase (βARK) and G-protein-coupled kinase (GRK). The second messenger kinases of βARK and GRK phosphorylate serine and/or threonine residues in the intracellular region of GPCRs following agonist-induced treatment (Kim et al., 2018). We and others have shown that ligands (hCG, eCG, eFSH, eel FSH, and eel LH) of glycoprotein hormone receptors result in the accumulation of cAMP responses (Hipkin et al., 1995a,b; Min et al., 2004; Bhaskaran & Ascoli, 2005; Kim et al., 2018; Byambaragchaa et al., 2021c,d, 2022). Several features of the post-endocytotic trafficking of receptors (mouse, rat, and human) that demonstrate routing of most internalized receptors to the lysosomes, and degradation of hormone-receptor complexes have been elucidated (Baratti-Elbaz et al., 1999; Kishi et al., 2001; Bhaskaran & Ascoli, 2005).

We analyzed the roles of phosphorylation sites in the uncoupling of eLH/CGR from cAMP accumulation in cells expressing eLH/CGR-wt and eLHCGR-t656. We tested the function of β-arrestin in the phosphorylation sites of the PathHunter Parental CHO-K1 cells expressing β-arrestins. In this present study, the C-terminal phosphorylation sites were critical for signal transduction of cAMP responsiveness in CHO-K1 cells. The EC50 value in the truncated potential phosphorylation sites of the C-terminal cytoplasmic tail was approximately 72% of that in eLH/ CGR-wt. The maximal response also dramatically decreased, similar to the EC50 value of the C-terminal deletion in eLH/CGR. These results are consistent with our previous data, indicating that the truncated phosphorylated sites in the cAMP response of eel FSHR-t614 decreased considerably to 60.4% of that of eel FSHR-wt, demonstrating that the maximal response of eel FSHR also decreased significantly by C-terminal deletion (Kim et al., 2018).

Other groups have reported significant phosphorylation sites in the signal transduction of receptors. The change of serine and threonine to alanine in the potential phosphorylation sites of rLH/CGR considerably reduces cAMP responsiveness (Wang et al., 1997). The truncated mutants (rLH/CGR-t631 and rLH/CGR-628) showed a delay in the early phase of desensitization, complete loss of PMA-induced desensitization, and an increased rate of downregulation (Wang et al., 1996). A deletion mutant at rLH/CGR-t631 impaired receptor phosphorylation. However, the cAMP response to Cholera toxin was also slightly elevated, and the Rmax level was 1.5-fold higher than that of wild-type receptor (Hipkin et al., 1995b). These findings suggest that the deleted mutant at the 631 amino acid of rLH/CGR is not phosphorylated and does not arise from insufficient hormone binding. Thus, our results in CHO-K1 cells suggest its primary role in post-translational phosphorylation.

In eFSHR, we also reported that the EC50 value and Rmax level in the eFSHR-t641 mutant were 0.58-fold lower than and 66% of that observed in eFSHR-wt in PathHunter Parental CHO-K1 cells (Seong et al., 2020). In this study, eLH/CGR deletion mutant recovered as much as the wild-type receptor. This may not have caused the deletion of the phosphorylation sites in the C-terminal region. One amino acid (serine) of the potential phosphorylation sites remained in eLH/CGR-t656, as shown in Fig. 1. The eFSHR-t641 deleted all potential phosphorylation sites in the intracellular region (Seong et al., 2020). Thus, we suggest that the phosphorylation sites in the C-terminal region of glycoprotein hormone receptors are indispensable for signal transduction through their receptor-ligand complex.

Additionally, β-arrestin, one of the main signal transduction pathways, is considered an important factor, indicating that cAMP and EC50 levels in the eLH/CGR-t656 mutant were restored to levels similar to those of the wild-type receptor in PathHunter Parental CHO-K1 cells. Our observations in cells expressing the β-arrestin kinase are not consistent with that in prior studies, indicating that phosphorylation sites are essential for signal transduction through G proteins. We hypothesize that a single phosphorylation site in the C-terminal region of eLH/CGR affects the post-translational phosphorylation of LH/CGRs, even though we have not analyzed the lack of phosphorylation in eLH/CGR-t656. The hFSHR-t678 mutant showed a greater degree of downregulation of cell surface receptors than that of hFSHR-wt in human embryonic kidney 293 (HEK-293) cells (Krishnamurthy et al., 2003). The hFSHR-t678 in mouse granulosa cells displayed approximately 60% loss of cell surface receptors despite approximately 40% loss of cell surface receptors in hFSHR-wt (Bhaskaran & Ascoli, 2005; Galet et al., 2003). These results are inconsistent with our results in PathHunter Parental CHO-K1 cells expressing β-arrestin 2 kinase. Thus, we suggest that eLH/CGR at the phosphorylation sites of the C-terminal cytoplasmic tail is necessary for signal transduction.

Recently, we also reported that eel FSHR-t635, in which all potential phosphorylation sites in the intracellular cytoplasmic tail were deleted, displayed an EC50 of approximately 60.4% of that of eel FSHR-wt (Kim et al., 2018). Although the rFSHR-truncated mutant did not affect phosphorylation or uncoupling (Hipkin et al., 1995a), the eFSHR-t641 in our study was considerably affected by cAMP responsiveness in cells expressing eFSHR-t641 with β-arrestin (Seong et al., 2020). Our data in the present study are consistent with that in our previous study, indicating that the deletion mutant of the C-terminal region greatly decreased the cAMP response.

In conclusion, eLH/CGR-wt in CHO-K1 cells responded to increased cAMP levels in a dose-dependent manner. The cAMP-mediated receptor was greatly reduced in the eLH/CGR-t656mutant that lacked phosphorylation sites, but one site of potential phosphorylation remained. The cAMP responsiveness in PathHunter Parental CHO-K1 cells was restored to the same level as the wild-type receptor. Thus, we suggest that C-terminal phosphorylation sites in eLH/CGR are necessary for signal transduction. Further studies are required to elucidate the signaling mechanisms that regulate internalization, loss of cell surface receptor, mitogen-activated protein (MAP) kinase, extracellular regulated kinase (ERK), and recycling in PathHunter Parental CHO-K1 cells.

Conflict of interests

The authors declare no potential conflict of interest.


This work was supported by a research grant from Hankyong National University in 2021.

Authors’ contributions

Conceptualization: Min KS.

Data curation: Byambaragchaa M.

Formal analysis: Joo HE.

Methodology: Byambaragchaa M.

Software: Kim SG.

Validation: Kim YJ, Park GE.

Investigation: Byambaragchaa M.

Writing-original draft: Byambaragchaa M.

Writing-review & editing: Min KS.

Ethics approval

This article does not require IRB/IACUC approval because there are no human and animal participants.



Ascoli M. 1996; Functional consequences of the phosphorylation of the gonadotropin receptors. Biochem Pharmacol. 52:1647-1655


Baratti-Elbaz C, Ghinea N, Lahuna O, Loosfelt H, Pichon C, Milgrom E. 1999; Internalization and recycling pathways of the thyrotropin receptor. Mol Endocrinol. 13:1751-1765


Beautrait A, Paradis JS, Zimmerman B, Giubilaro J, Nikolajev L, Armando S, Kobayashi H, Yamani L, Namkung Y, Heydenreich FM, Khoury E, Audet M, Roux PP, Veprintsev DB, Laporte SA, Bouvier M. 2017; A new inhibitor of the β-arrestin/AP2 endocytic complex reveals interplay between GPCR internalization and signalling. Nat Commun. 8:15054


Bhaskaran RS, Ascoli M. 2005; The post-endocytotic fate of the gonadotropin receptors is an important determinant of the desensitization of gonadotropin responses. J Mol Endocrinol. 34:447-457


Byambaragchaa M, Ahn TY, Choi SH, Kang MH, Min KS. 2022; Functional characterization of naturally-occurring constitutively activating/inactivating mutations in equine follicle-stimulating hormone receptor. Anim Biosci. 35:399-409


Byambaragchaa M, Choi SH, Joo HE, Kim SG, Kim YJ, Park GE, Kang MH, Min KS. 2021c; Specific biological activity of equine chorionic gonadotropin (eCG) glycosylation sites in cells expressing equine luteinizing hormone/CG (eLH/CG) receptor. Dev Reprod. 25:199-211


Byambaragchaa M, Choi SH, Kim DW, Min KS. 2021a; Constitutive activating eel luteinizing hormone receptors induce constitutively signal transduction and inactivating mutants impair biological activity. Dev Reprod. 25:133-143


Byambaragchaa M, Choi SH, Kim DW, Min KS. 2021b; Cell-surface loss of constitutive activating and inactivating mutants of eel luteinizing hormone receptors. Dev Reprod. 25:225-234


Byambaragchaa M, Kim JS, Park HK, Kim DJ, Hong SM, Kang MH, Min KS. 2020; Constitutive activation and inactivation of mutations inducing cell surface loss of receptor and impairing of signal transduction of agonist-stimulated eel follicle-stimulating hormone receptor. Int J Mol Sci. 21:7075


Byambaragchaa M, Lee SY, Kim DJ, Kang MH, Min KS. 2018; Signal transduction of eel luteinizing hormone receptor (eelLHR) and follicle stimulating hormone receptor (eelFSHR) by recombinant equine chorionic gonadotropin (rec-eCG) and native eCG. Dev Reprod. 22:55-64


Byambaragchaa M, Park A, Gil SJ, Lee HW, Ko YJ, Choi SH, Kang MH, Min KS. 2021d; Luteinizing hormone-like and follicle-stimulating hormone-like activities of equine chorionic gonadotropin β-subunits mutants in cells expressing rat luteinizing hormone/chorionic gonadotropin receptor and rat follicle-stimulating hormone receptor. Anim Cells Syst. 25:171-181


Byambaragchaa M, Seong HK, Choi SH, Kim DJ, Kang MH, Min KS. 2021e; Constitutively activating mutants of equine LH/CGR constitutively induce signal transduction and inactivating mutations impair biological activity and cell-surface receptor loss in vitro. Int J Mol Sci. 22:10723


Duvernay MT, Zhou F, Wu G. 2004; A conserved motif for the transport of G protein-coupled receptors from the endoplasmic reticulum to the cell surface. J Biol Chem. 279:30741-30750


Galet C, Hirakawa T, Ascoli M. 2004; The postendocytotic trafficking of the human lutropin receptor is mediated by a transferable motif consisting of the C-terminal cysteine and an upstream leucine. Mol Endocrinol. 18:434-446


Galet C, Min L, Narayanan R, Kishi M, Weigel NL, Ascoli M. 2003; Identification of a transferable two-amino-acid motif (GT) present in the C-terminal tail of the human lutropin receptor that redirects internalized G protein-coupled receptors from a degradation to a recycling pathway. Mol Endocrinol. 17:411-422


Hipkin RW, Liu X, Ascoli M. 1995a; Truncation of the C-terminal tail of the follitropin receptor does not impair the agonist- or phorbol ester-induced receptor phosphorylation and uncoupling. J Biol Chem. 270:26683-26689


Hipkin RW, Wang Z, Ascoli M. 1995b; Human chorionic gonadotropin (CG)- and phorbol ester-stimulated phosphorylation of the luteinizing hormone/CG receptor maps to serines 635, 639, 649, and 652 in the C-terminal cytoplasmic tail. Mol Endocrinol. 9:151-158


Hirakawa T, Ascoli M. 2003; The lutropin/choriogonadotropin receptor-induced phosphorylation of the extracellular signal-regulated kinases in Leydig cells is mediated by a protein kinase a-dependent activation of ras. Mol Endocrinol. 17:2189-2200


Jones B, McGlone ER, Fang Z, Pickford P, Corrêa IR, Oishi A, Jockers R, Inoue A, Kumar S, Görlitz F, Dunsby C, French PMW, Rutter GA, Tan T, Tomas A, Bloom SR. 2021; Genetic and biased agonist-mediated reductions in β-arrestin recruitment prolong cAMP signaling at glucagon family receptors. J Biol Chem. 296:100133


Kim JM, Byambaragchaa M, Kang MH, Min KS. 2018; The C-terminal phosphorylation sites of eel follicle-stimulating hormone receptor are important role in the signal transduction. Dev Reprod. 22:143-153


Kim JS, Byambaragchaa M, Min KS. 2019; Characterization of constitutively activating eel follicle-stimulating hormone receptor. J Anim Reprod Biotechnol. 34:267-271


Kishi M, Liu X, Hirakawa T, Reczek D, Bretscher A, Ascoli M. 2001; Identification of two distinct structural motifs that, when added to the C-terminal tail of the rat LH receptor, redirect the internalized hormone-receptor complex from a degradation to a recycling pathway. Mol Endocrinol. 15:1624-1635


Krishnamurthy H, Kishi H, Shi M, Galet C, Bhaskaran RS, Hirakawa T, Ascoli M. 2003; Postendocytotic trafficking of the follicle-stimulating hormone (FSH)-FSH receptor complex. Mol Endocrinol. 17:2162-2176


Lee SY, Byambaragchaa M, Choi SH, Kang HJ, Kang MH, Min KS. 2021; Roles of N-linked and O-linked glycosylation sites in the activity of equine chorionic gonadotropin in cells expressing rat luteinizing hormone/chorionic gonadotropin receptor and follicle-stimulating hormone receptor. BMC Biotechnol. 21:52


Lee SY, Byambaragchaa M, Kim JS, Seong HK, Kang MH, Min KS. 2017; Biochemical characterization of recombinant equine chorionic gonadotropin (rec-eCG), using CHO cells and PathHunter Parental cells expressing equine luteinizing hormone/chorionic gonadotropin receptors (eLH/CGR). J Life Sci. 27:864-872.


Martemyanov KA, Garcia-Marcos M. 2018; Making useful gadgets with miniaturized G proteins. J Biol Chem. 293:7474-7475


Min KS, Byambaragchaa M, Choi SH, Joo HE, Kim SG, Kim YJ, Park GE. 2021; Activating and inactivating mutations of the human, rat, equine and eel luteinizing hormone/chorionic gonadotropin receptors (LH/CGRs). J Anim Reprod Biotechnol. 36:169-174


Min KS, Hiyama T, Seong HH, Hattori N, Tanaka S, Shiota K. 2004; Biological activities of tethered equine chorionic gonadotropin (eCG) and its deglycosylated mutants. J Reprod Dev. 50:297-304


Min KS, Liu X, Fabritz J, Jaquette J, Abell AN, Ascoli M. 1998; Mutations that induce constitutive activation and mutations that impair signal transduction modulate the basal and/or agonist-stimulated internalization of the lutropin/choriogonadotropin receptor. J Biol Chem. 273:34911-34919


Min KS, Park JJ, Byambaragchaa M, Kang MH. 2019; Characterization of tethered equine chorionic gonadotropin and its deglycosylated mutants by ovulation stimulation in mice. BMC Biotechnol. 19:60


Min KS, Park JJ, Lee SY, Byambaragchaa M, Kang MH. 2020; Comparative gene expression profiling of mouse ovaries upon stimulation with natural equine chorionic gonadotropin (N-eCG) and tethered recombinant-eCG (R-eCG). BMC Biotechnol. 20:59


Nakamura K, Krupnick JG, Benovic JL, Ascoli M. 1998; Signaling and phosphorylation-impaired mutants of the rat follitropin receptor reveal an activation- and phosphorylation-independent but arrestin-dependent pathway for internalization. J Biol Chem. 273:24346-24354


Pakharukova N, Masoudi A, Pani B, Staus DP, Lefkowitz RJ. 2020; Allosteric activation of proto-oncogene kinase Src by GPCR-beta-arrestin complexes. J Biol Chem. 295:16773-16784


Park JJ, Seong HK, Kim JS, Munkhzaya B, Kang MH, Min KS. 2017; Internalization of rat FSH and LH/CG receptors by rec-eCG in CHO-K1 cells. Dev Reprod. 21:111-120


Pierce KL, Premont RT, Lefkowitz RJ. 2002; Seven-transmembrane receptors. Nat Rev Mol Cell Biol. 3:639-650


Sánchez-Yagüe J, Rodríguez MC, Segaloff DL, Ascoli M. 1992; Truncation of the cytoplasmic tail of the lutropin/choriogonadotropin receptor prevents agonist-induced uncoupling. J Biol Chem. 267:7217-7220


Seong HK, Choi SH, Byambaragchaa M, Min KS. 2020; Signal transduction of C-terminal phosphorylation sites for equine follicle stimulating hormone receptor (eFSHR). J Anim Reprod Biotechnol. 35:155-162


Slosky LM, Bai Y, Toth K, Ray C, Rochelle LK, Badea A, Chandrasekhar R, Pogorelov VM, Abraham DM, Atluri N, Peddibhotla S, Hedrick MP, Hershberger P, Maloney P, Yuan H, Li Z, Wetsel WC, Pinkerton AB, Barak LS, Caron MG. 2020; β-Arrestin-biased allosteric modulator of NTSR1 selectively attenuates addictive behaviors. Cell. 181:1364-1379


Wan Q, Okashah N, Inoue A, Nehmé R, Carpenter B, Tate CG, Lambert NA. 2018; Mini G protein probes for active G protein-coupled receptors (GPCRs) in live cells. J Biol Chem. 293:7466-7473


Wang Z, Hipkin RW, Ascoli M. 1996; Progressive cytoplasmic tail truncations of the lutropin-choriogonadotropin receptor prevent agonist- or phorbol ester-induced phosphorylation, impair agonist- or phorbol ester-induced desensitization, and enhance agonist-induced receptor down-regulation. Mol Endocrinol. 10:748-759


Wang Z, Liu X, Ascoli M. 1997; Phosphorylation of the lutropin/choriogonadotropin receptor facilitates uncoupling of the receptor from adenylyl cyclase and endocytosis of the bound hormone. Mol Endocrinol. 11:183-192


Zhang M, Tao YX, Ryan GL, Feng X, Fanelli F, Segaloff DL. 2007; Intrinsic differences in the response of the human lutropin receptor versus the human follitropin receptor to activating mutations. J Biol Chem. 282:25527-25539